Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Feb
6
2017
The Department of Culture, Media and Sport’s Combatting Doping in Sport Inquiry: Origin, Scope and Powers Squire Patton Boggs (US) LLP
Feb
6
2017
Food Fight: More Labeling Litigation in 2017 ArentFox Schiff LLP
Feb
6
2017
When Does a Suggestion Become an Invention? Squire Patton Boggs (US) LLP
Feb
6
2017
Two States Move to Require COOL Labeling for Beef: Country of Origin Keller and Heckman LLP
Feb
6
2017
More Than 25% of New Molecular Entities Approved in 2016 Are Personalized Medicines Foley & Lardner LLP
Feb
3
2017
Victory for the Right to be Smoke-Free Coalition and E-Vapor Industry in Indiana Keller and Heckman LLP
Feb
3
2017
Menu Labeling Legislation Would Ease Some of FDA’s Upcoming Requirements Keller and Heckman LLP
Feb
2
2017
FDA Clarifies “Intended Use” for Drugs, Devices, and Tobacco Products McDermott Will & Emery
Feb
2
2017
EPA Seeks Comments On GHG Analysis Of Sugar Beets For Biofuel Feedstock Bergeson & Campbell, P.C.
Feb
2
2017
FDA Adopts New Designation Process for Regenerative Advanced Therapies Epstein Becker & Green, P.C.
Feb
2
2017
Antidote for Acetaminophen Overdoses Not Invalid as Either Derived From Another or Obvious Over the Prior Art Hunton Andrews Kurth
Feb
2
2017
AkzoNobel To Produce Biobased Polymers With Itaconix Bergeson & Campbell, P.C.
Feb
2
2017
FDA Releases Tips for Industry on Crafting Food Guidance Documents Keller and Heckman LLP
Feb
1
2017
OECD Publishes Report on Alternative Testing Strategies in Risk Assessment of Manufactured Nanomaterials Bergeson & Campbell, P.C.
Feb
1
2017
California Court Tentatively Dismisses Monstano’s Lawsuit Against OEHHA to Block Addition of Glyphosate to Proposition 65 List Bergeson & Campbell, P.C.
Feb
1
2017
To the Federal Circuit, Some PTAB Petitioners Have No Appeal Whatsoever K&L Gates
Feb
1
2017
FDA Denies Methylmercury Labeling Petition for Seafood Keller and Heckman LLP
Feb
1
2017
New Hampshire Finalizes Opioid Prescribing Rules Foley & Lardner LLP
Feb
1
2017
European Commission’s Joint Research Centre Releases Final Baseline Study on Non-harmonized Food-Contact Materials Keller and Heckman LLP
Jan
31
2017
FDA Issues Draft Guidance on Payor Communications McDermott Will & Emery
Jan
31
2017
Managing a Dairy in Crisis: A Lender’s Guide Varnum LLP
Jan
31
2017
Proposed ‘Dairy Pride Act’ Creates Controversy Keller and Heckman LLP
Jan
31
2017
Supreme Court to Consider BPCIA Requirements for Biosimilars McDermott Will & Emery
Jan
30
2017
New Jersey Supreme Court Deals Blow to Drug and Device Manufactures Seeking to Avoid Forum Shopping Barnes & Thornburg LLP
Jan
30
2017
Nonprofit Group Tells FDA High-Sugar Foods Should Not Bear “Healthy” Claims Keller and Heckman LLP
Jan
28
2017
Top International News in Chemical Policy and Regulation - January 27, 2017: Europe Bergeson & Campbell, P.C.
Jan
28
2017
Top International News in Chemical Policy and Regulation- January 27, 2017: Americas Bergeson & Campbell, P.C.
Jan
27
2017
FDA Finalizes New Rule "Clarifying" When a Tobacco Product is Actually a Medical Product Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins